Baricitinib Safety for Events of Special Interest in Populations at Risk: Analysis from Randomised Trial Data Across Rheumatologic and Dermatologic IndicationsBrief Report Published on 2023-02-202024-09-04 Journal: Advances in therapy [Category] 대상포진, [키워드] adverse events Baricitinib jak inhibitors MACE malignancy Mortality Safety serious infection VTE [DOI] 10.1007/s12325-023-02445-w PMC 바로가기 [Article Type] Brief Report
Integrative analyses of genes about venous thromboembolism: An umbrella review of systematic reviews and meta-analysesArticle Published on 2022-10-282022-11-16 Journal: Medicine [Category] meta-analysis, 변종, [키워드] activating Analysis appraisal checklist conducted COVID-19 vaccination criteria Critical cumulative database Effect effect size eligible endothelial environmental risk factor Epidemiology estimates etiology Evidence Genetic genetic risk factor Genetic variant Genetic variations had more heterogeneity Human identify Intervention meta-analyses Meta-analysis MTHFR network p values performed polymorphism protease Protein prothrombin provided receptor respond review risk Risk factors Sample size selected surgical systematic review variable variant Venice venous Venous Thromboembolism VTE was performed were used [DOI] 10.1097/MD.0000000000031162 PMC 바로가기
COVID-19 outcomes in patients with Dermatomyositis: A registry-based cohort analysisResearch article Published on 2022-10-012022-10-05 Journal: Seminars in arthritis and rheumatism [Category] 변종, [키워드] 1:1 Acute kidney injury acute respiratory distress adjust African American AKI Analysis ARDS association Black race Cancer patients cohort analysis confounders Control controls COVID-19 database dermatomyositis determine develop Disease activity drug Gender General population glucocorticoid heterogeneous nature High dose higher odd hospitalisation ICU admission identify ILD Immunosuppressant immunosuppressive individual Infection Interstitial lung disease lower risk male mechanical ventilation Mortality neoplasm Neoplasms outcome outcomes Patient patients with COVID-19 Precaution receiving renal replacement therapy required retrieved retrospective data rheumatic disease risk RRT score Sepsis severe COVID-19 Severe COVID-19 Infection severity of COVID-19 stroke subgroup analysis syndrome therapy Treatment Venous Thromboembolism VTE was used with COVID-19 [DOI] 10.1016/j.semarthrit.2022.152034 [Article Type] Research article
C-reactive protein, immunothrombosis and venous thromboembolismArticle Published on 2022-09-132022-11-15 Journal: Frontiers in Immunology [Category] 바이오마커, [키워드] activating amplifying appear binding Biomarker C-reactive protein classical Clinical data Clinical practice clinical utility Complement pathway condition conserved COVID-19 CRP destabilized dissociate Effect elevated Elevation Evidence Features immunothrombosis Infection Inflammation Inflammatory bowel disease Inflammatory response isoform marker membrane monomeric Pathogenesis Platelet pro-inflammatory pro-thrombotic Prophylactic Protein raise required Sepsis subset therapeutic strategy Thromboinflammation thrombosis tissue damage triggering utility Venous Thromboembolism VTE VTE risk with COVID-19 [DOI] 10.3389/fimmu.2022.1002652 PMC 바로가기
COVID-19 associated Venous Thromboembolism (VTE) burden in Black women: Findings of Veterans Affairs COVID-19 Shared DataCorrespondence Published on 2022-09-012022-10-05 Journal: Thrombosis research [Category] 유전자 메커니즘, [키워드] Affair black COVID-19 finding Venous Thromboembolism veteran veterans VTE women [DOI] 10.1016/j.thromres.2022.07.007 [Article Type] Correspondence
P156. Mortality of operative spinal fractures in COVID-19 positive patients using data from a national databaseConference abstract Published on 2022-09-012022-10-05 Journal: The Spine Journal [Category] 진단, [키워드] Abstract Acute kidney injury acute respiratory distress age AKI all-cause mortality Analysis Antigen ARDS baseline body mass index Care Clinical data Cohort cohort study collected data comparable complications control group COVID COVID-19 COVID-19 negative COVID-19 pandemic COVID-19 positive patient criteria Critical database diagnostic drugs event examined FDA Gender group Health include increase increased mortality increased risk individual information Intervention Lower management Mortality National Older operative outcome Patient patients PCR performed positive Primary outcome question raise Ratio required Research resource RT-PCR Sepsis Spinal cord injury subsequent surgical sustained syndrome tested total population upper Venous Thromboembolism VTE was collected women [DOI] 10.1016/j.spinee.2022.06.413 [Article Type] Conference abstract
Coagulation Abnormalities and Management in Hospitalized Pediatric Patients With COVID-19COVID-19로 입원한 소아 환자의 응고 이상 및 관리Article Published on 2022-07-012022-09-11 Journal: The Pediatric Infectious Disease Journal [Category] COVID19(2023년), SARS, 치료기술, [키워드] Abnormalities abnormality Anticoagulant anticoagulation Antithrombotic association change children Clinical outcome Coagulation coronavirus disease Coronavirus disease 2019 Course COVID-19 D-dimer level discharge enrolled Evidence Hospitalized hospitalized patient incidence increased risk initiated lack management median median age normalization outcome Patient patients pediatric Population Prophylactic prophylactic anticoagulation Prophylaxis Prospective Study risk risk factor selected severe cases severe COVID-19 severity tendency the disease thromboembolic Thromboembolic event Thromboembolic events Thromboprophylaxis thrombotic thrombotic complication Thrombotic complications Venous Thromboembolism VTE was performed with COVID-19 [DOI] 10.1097/INF.0000000000003545 PMC 바로가기 [Article Type] Article
COVID-19 and venous thromboembolism risk in patients with sickle cell diseaseShort communication Published on 2022-06-272022-10-05 Journal: Blood advances [Category] 진단, [키워드] adjusted adjusted relative risk baseline characteristics causes Cell confidence interval COVID-19 COVID-19 infection disease group Health Hospitalization Hospitalized increase life-threatening log multisite no significant difference Patient patients hospitalized Poisson regression model Research risk risk ratio robust SCD severe COVID-19 illness Severe COVID-19 Infection Thromboembolism Venous Thromboembolism VTE VTE risk with COVID-19 [DOI] 10.1182/bloodadvances.2022007219 [Article Type] Short communication
American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis for patients with COVID-19: March 2022 update on the use of anticoagulation in critically ill patientsPractice guideline Published on 2022-06-242022-10-05 Journal: Blood advances [Category] 임상, [키워드] anticoagulation applied approach assessment bleeding Care clinician Clinicians Critical Critically ill patient development Evidence Health hematology increased risk intensity outcome Patient patients patients with COVID-19 professional question Randomized controlled trial recommendations risk Society subject Support supported Thromboprophylaxis thrombotic university Venous Thromboembolism VTE [DOI] 10.1182/bloodadvances.2022007940 [Article Type] Practice guideline
American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: January 2022 update on the use of therapeutic-intensity anticoagulation in acutely ill patientsPractice guideline Published on 2022-05-032022-10-05 Journal: Blood advances [Category] 임상, 진단, [키워드] acute illness acutely ill patient Anticoagulants anticoagulation applied approach assessment bleeding Care clinician Clinicians development Evidence favor Health hematology increased risk intensity low molecular weight outcome Patient patients patients with COVID-19 performed professional question Randomized controlled trial recommendations risk Society subject Support supported Thromboprophylaxis thrombosis university Venous Thromboembolism VTE [DOI] 10.1182/bloodadvances.2022007561 [Article Type] Practice guideline